Vienna Challenge Chamber

Recent papers from Vienna Challenge Chamber

1. Point-of-care testing of cardiovascular risk factors in Viennese community pharmacies: A cross-sectional studyPreventive Medicine Reports · 2025
2. Moisture sources and rainfall water stable isotopes during the recent triple-dip La Niña in coastal ArgentinaHydrological Sciences Journal · 2025
3. Decongestant Effect of “Coldamaris Akut”, a Carrageenan- and Sorbitol-Containing Nasal Spray in Seasonal Allergic RhinitisInternational Journal of General Medicine · 2024
4. Alleviation of Allergic Rhinoconjunctivitis Symptoms in Participants Treated with a 0.005% Tacrolimus Eye-Drop SolutionClinical ophthalmology · 2024
5. Demonstration of a Decongestant Effect of “Coldamaris Akut” Compared to Saline Nasal Spray in Participants Suffering from Seasonal Allergic Rhinitis2024
6. Carrageenan-Containing Nasal Spray Alleviates Allergic Symptoms in Participants with Grass Pollen Allergy: A Randomized, Controlled, Crossover Clinical TrialInternational Journal of General Medicine · 2024
7. Carrageenan-containing nasal spray alleviates allergic symptoms in subjects with grass pollen allergy: A randomized, controlled, crossover clinical trial2023
8. Allergen challenge tests in allergen immunotherapy: State of the artAllergologie select · 2023
9. Cosensitization to the 3 Nonhomologous Major Cashew Allergens Ana o 1, Ana o 2, and Ana o 3 Is Caused by IgE Cross-reactivityJournal of Investigational Allergology and Clinical Immunology · 2022
10. IgE reactivity patterns in Asian and central European cockroach-sensitized patients reveal differences in primary sensitizing allergen sourcesJournal of Allergy and Clinical Immunology Global · 2022
11. Update on the use of allergen challenge chambers in immunotherapy: clinical implications.2022
12. Update on the use of allergen challenge chambers in immunotherapy: clinical implicationsCurrent Opinion in Allergy and Clinical Immunology · 2022
13. Development and validation of combined symptom‐medication scores for allergic rhinitis*Allergy · 2021
14. Dogmas, challenges, and promises in phase III allergen immunotherapy studiesWorld Allergy Organization Journal · 2021
15. Allergic Rhinitis in Childhood and the New EUFOREA AlgorithmFrontiers in Allergy · 2021
16. IgE Epitopes of the House Dust Mite Allergen Der p 7 Are Mainly Discontinuous and ConformationalFrontiers in Immunology · 2021
17. A meta‐analysis on allergen‐specific immunotherapy using MCT® (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitisClinical and Translational Allergy · 2021
18. Technical standards in allergen exposure chambers worldwide – an EAACI Task Force ReportAllergy · 2021
19. Burden of allergic rhinitis and impact of MP-AzeFlu from the patient perspective: pan European patient surveyCurrent Medical Research and Opinion · 2021
20. Expression in Escherichia coli and Purification of Folded rDer p 20, the Arginine Kinase From Dermatophagoides pteronyssinus: A Possible Biomarker for Allergic AsthmaAllergy Asthma and Immunology Research · 2020